Pro-Pharmaceuticals, Inc.
4Patents
1Active
4Granted
32Portfolio score
Filing activity: Mar 27, 2001 → Feb 25, 2008 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7893252B2 | Selectively depolymerized galactomannan polysaccharide | Human Necessities | 21 | Active |
| US7012068B2 | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer | Human Necessities | 9 | Expired |
| US6645946B1 | Delivery of a therapeutic agent in a formulation for reduced toxicity | Human Necessities | 8 | Expired |
| US6642205B2 | Methods and compositions for reducing side effects in chemotherapeutic treatments | Human Necessities | 7 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.